Jones Se
- Pathology and Forensic Medicine top 10%
- Lymphoma Diagnosis and Treatment 9
- Genetic factors in colorectal cancer 3
-
- Cancer Treatment and Pharmacology 8
- Dermatology top 10%
-
- Chemotherapy-induced cardiotoxicity and mitigation 3
-
- Lung Cancer Treatments and Mutations 7
-
- Neuroendocrine Tumor Research Advances 4
-
- Cancer therapeutics and mechanisms 3
-
- Radiopharmaceutical Chemistry and Applications 2
- Journals
- Munich Personal RePEc Archive (Ludwig Maximilian University of Munich) (4 papers)PubMed (29 papers)Yearbook of pediatric endocrinology (1 paper)
- Partner nations
- United StatesUnited Kingdom
In The Last Decade
Jones Se
34 papers receiving 379 citations
Peers
Comparison fields: 5 of 76
- Pathology and Forensic Medicine 195
- Oncology 166
- Dermatology 53
- Genetics 58
- Cardiology and Cardiovascular Medicine 65
Countries citing papers authored by Jones Se
This map shows the geographic impact of Jones Se's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Jones Se with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Jones Se more than expected).
Fields of papers citing papers by Jones Se
This network shows the impact of papers produced by Jones Se. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Jones Se. The network helps show where Jones Se may publish in the future.
Co-authorship network
The 24 scholars most cited alongside Jones Se, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2018 | 11 | |
| 2 | Getting the balance right. Pulse oximetry and inspired oxygen concentration. | 1995 | 2 |
| 3 | Salvage treatment of unfavorable non-Hodgkin's lymphoma with cisplatin, amsacrine, and mitoguazone: a Southwest Oncology Group Pilot Study. | 1986 | 8 |
| 4 | Follicular lymphoma--do no harm. | 1986 | 6 |
| 5 | Histological demonstration of spirochaetes: a method of preparing control sections. | 1985 | 2 |
| 6 | Gallium nitrate in malignant lymphoma: a Southwest Oncology Group study. | 1983 | 24 |
| 7 | Vineland social maturity scale norm examined--the Wisconsin experience with 0- to 3-year-old children. | 1982 | 2 |
| 8 | Mistaken clinical and pathologic diagnoses of Hodgkin's disease: a Southwest oncology group study. | 1982 | 35 |
| 9 | Treatment of recurrent lymphomas with vincristine, BCNU, doxorubicin, and prednisone (VBAP): a Southwest Oncology Group Study. | 1981 | 1 |
| 10 | Phase II trial of vindesine in the treatment of lymphomas, breast cancer, and other solid tumors. | 1981 | 9 |
| 11 | 1-year followup of cardiac status after adriamycin therapy. | 1980 | 9 |
| 12 | Importance of staging in Hodgkin's disease. | 1980 | 8 |
| 13 | Studies on responses by 'resident' rats housed in different ways to intruders of differing endocrine status [proceedings]. | 1979 | 4 |
| 14 | Combination chemotherapy for mycosis fungoides: a Southwest Oncology Group study. | 1979 | 37 |
| 15 | Noninvasive cardiac evaluation of patients receiving adriamycin. | 1978 | 19 |
| 16 | Systematic re-staging in the management of non-Hodgkin's lymphomas. | 1977 | 7 |
| 17 | Combination chemotherapy with adriamycin and cyclophosphamide (with or without radiation therapy) for carcinoma of the lung. | 1977 | 11 |
| 18 | Phase II trial of piperazinedione in Hodgkin's disease, non-Hodgkin's lymphoma, and multiple myeloma: a Southwest Oncology Group study. | 1977 | 5 |
| 19 | Tumor viruses and human cancer. Leukemia and RNA tumor viruses. | 1977 | 2 |
| 20 | Adriamycin and 5-fluorouracil in the treatment of advanced hepatoma: a Southwest Oncology Group study. | 1977 | 18 |
About Jones Se
Jones Se is a scholar working on Pathology and Forensic Medicine, Oncology, Hepatology, Pulmonary and Respiratory Medicine and Reproductive Medicine, having authored 34 papers that have together received 443 indexed citations. Recurring topics across this work include Lymphoma Diagnosis and Treatment (9 papers), Cancer Treatment and Pharmacology (8 papers), Lung Cancer Treatments and Mutations (7 papers), Neuroendocrine Tumor Research Advances (4 papers), Genetic factors in colorectal cancer (3 papers), Cancer therapeutics and mechanisms (3 papers), Chemotherapy-induced cardiotoxicity and mitigation (3 papers) and Radiopharmaceutical Chemistry and Applications (2 papers). The work is most often cited by research in Pathology and Forensic Medicine (195 citations), Oncology (166 citations), Dermatology (53 citations), Genetics (58 citations) and Cardiology and Cardiovascular Medicine (65 citations). Jones Se has collaborated with scholars based in United States and United Kingdom. Frequent co-authors include Coltman Ca, Salmon Se, Baker Lh, BG Durie, Weick Jk, R I Fisher, Talley Rw, Gerald Bennett, Hewlett Js and Lyubica Dabich. Their work appears in journals such as Munich Personal RePEc Archive (Ludwig Maximilian University of Munich), PubMed and Yearbook of pediatric endocrinology.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.